Canarypox Virus-Induced Maturation of Dendritic Cells Is Mediated by Apoptotic Cell Death and Tumor Necrosis Factor Alpha Secretion
Open Access
- 1 December 2000
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 74 (23) , 11999-12004
- https://doi.org/10.1128/jvi.74.23.11329-11338.2000
Abstract
TT virus (TTV) is a recently identified widespread DNA virus of humans that produces persistent viremia in the absence of overt clinical manifestations. In an attempt to shed light on the dynamics of chronic infection, we measured the levels of TTV in the plasma of 25 persistently infected patients during the first 3 months of alpha interferon (IFN-α) treatment for concomitant hepatitis C virus (HCV) infection. The first significant decline of TTV loads was observed at day 3 versus day 1 for HCV. Subsequently, the loads of TTV became progressively lower in most patients, but some initial responders relapsed before the end of the follow-up, suggesting that at least in some subjects the effects of IFN on TTV can be very short-lived. No correlation between the responses of TTV and HCV to therapy was found. Fitting the viremia data obtained during the first week of treatment into previously developed mathematical models showed that TTV sustains very active chronic infections, with over 90% of the virions in plasma cleared and replenished daily and a minimum of approximately 3.8 × 1010 virions generated per day. Low levels of TTV were occasionally detected in the peripheral blood mononuclear cells of patients who had cleared plasma viremia, thus corroborating previous results showing that these cells may support TTV replication and/or persistence.Keywords
This publication has 72 references indexed in Scilit:
- Consequences of Cell DeathThe Journal of Experimental Medicine, 2000
- Antigen gene transfer to cultured human dendritic cells using recombinant avipoxvirus vectorsCancer Gene Therapy, 1999
- Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteersAIDS, 1998
- Immunogenicity and Protective Efficacy of a Human Immunodeficiency Virus Type 2 Recombinant Canarypox (ALVAC) Vaccine Candidate in Cynomolgus MonkeysThe Journal of Infectious Diseases, 1996
- Human safety and immunogenicity of a canarypox-rabies glycoprotein recombinant vaccine: an alternative poxvirus vector systemVaccine, 1996
- Highly Attenuated HIV Type 2 Recombinant Poxviruses, but Not HIV-2 RecombinantSalmonellaVaccines, Induce Long-Lasting Protection in Rhesus MacaquesAIDS Research and Human Retroviruses, 1995
- Induction of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific Cytolytic T Lymphocyte Responses in Seronegative Adults by a Nonreplicating, Host-Range-Restricted Canarypox Vector (ALVAC) Carrying the HIV-1MN env GeneThe Journal of Infectious Diseases, 1995
- Biological and immunogenic properties of a canarypox-rabies recombinant, ALVAC-RG (vCP65) in non-avian speciesVaccine, 1995
- Dendritic Cells Exposed to Human Immunodeficiency Virus Type-1 Transmit a Vigorous Cytopathic Infection to CD4 + T CellsScience, 1992
- The Dendritic Cell System and its Role in ImmunogenicityAnnual Review of Immunology, 1991